Recombinant Humanized monoclonal antibody expressed in CHO binding to Human IL10. This is a humanized anti-IL-10 antibody under investigation as an anti-immunosuppressive agent during visceral Leishmaniasis. Of note, there are no ongoing clinical trials that evaluate the therapeutic potential of cytokines from the IL-10 family (or their inhibitors) in cancer patients.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
PFBW-080 | Rat Anti-IL10 Recombinant Antibody (clone 9D7); Fab Fragment | Neut | Rat Fab |
HPAB-0022-YC-F(E) | Human Anti-IL10 Recombinant Antibody; Fab Fragment (HPAB-0022-YC-F(E)) | ELISA, Neut | Humanized Fab |
HPAB-0223CQ-F(E) | Mouse Anti-IL10 Recombinant Antibody (clone B-N10); Fab Fragment | ELISA, FC, Block | Mouse Fab |
HPAB-0224CQ-F(E) | Human Anti-IL10 Recombinant Antibody (clone BT-063); Fab Fragment | ELISA, FC, Block | Humanized Fab |
HPAB-0344-WJ-F(E) | Human Anti-IL10 Recombinant Antibody (clone 12G8); Fab Fragment | ELISA | Humanized Fab |
There are currently no Customer reviews or questions for TAB-390CL. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.